Literature DB >> 27913945

The Effect of Prophylactic Central Neck Dissection on Locoregional Recurrence in Papillary Thyroid Cancer After Total Thyroidectomy: A Systematic Review and Meta-Analysis : pCND for the Locoregional Recurrence of Papillary Thyroid Cancer.

Wenjing Zhao1, Lei You1, Xianming Hou1, Shaobo Chen1, Xiaoxia Ren1, Ge Chen2, Yupei Zhao3.   

Abstract

BACKGROUND: The use of prophylactic central neck dissection (pCND) for papillary thyroid cancer (PTC) without clinical evidence of nodal metastasis (cN0) remains controversial. This study was designed to examine whether pCND for PTC affected locoregional recurrence (LRR).
METHODS: A systematic review was performed to compare the LRR between patients with PTC who underwent total thyroidectomy (TT) and pCND and those who underwent TT alone. The primary outcome was LRR. Other outcomes, including postoperative radioiodine (RAI) ablation and surgically related complications, were evaluated. A meta-analysis was performed using the random-effects model.
RESULTS: We included 17 studies, which comprised 4437 patients. Patients in the TT+pCND group had a significantly reduced risk of LRR (risk ratio [RR] = 0.66; 95% confidence interval [CI]: 0.49-0.90; P = 0.008). The LRR in the central neck compartment (RR = 0.35; 95% CI 0.18-0.68; P = 0.002) was significantly lower in the TT+pCND group, whereas the LRR in the lateral neck compartment was similar between the two groups. Compared with the TT alone group, patients in the TT+pCND group tended to receive higher RAI (74.6% vs. 59.9%) and experience temporary hypocalcemia (odds ratio [OR] = 2.37; 95% CI 1.89-2.96; P < 0.00001), permanent hypocalcemia (OR = 1.93; 95% CI 1.05-3.57; P = 0.03), and increased overall morbidity (OR = 2.56; 95% CI 1.75-3.74; P < 0.00001).
CONCLUSIONS: This meta-analysis suggested that although pCND reduced the LRR in PTC-specifically in the central neck compartment-it was accompanied by an increased rate of postoperative hypocalcemia. However, the evidence is limited and randomized, controlled trials are needed to clarify this role further.

Entities:  

Mesh:

Year:  2016        PMID: 27913945     DOI: 10.1245/s10434-016-5691-4

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  30 in total

Review 1.  Morbidity of central neck dissection for papillary thyroid cancer.

Authors:  Davide Lombardi; Remo Accorona; Alberto Paderno; Carlo Cappelli; Piero Nicolai
Journal:  Gland Surg       Date:  2017-10

Review 2.  Management of the Neck in Well-Differentiated Thyroid Cancer.

Authors:  Panagiotis Asimakopoulos; Ashok R Shaha; Iain J Nixon; Jatin P Shah; Gregory W Randolph; Peter Angelos; Mark E Zafereo; Luiz P Kowalski; Dana M Hartl; Kerry D Olsen; Juan P Rodrigo; Vincent Vander Poorten; Antti A Mäkitie; Alvaro Sanabria; Carlos Suárez; Miquel Quer; Francisco J Civantos; K Thomas Robbins; Orlando Guntinas-Lichius; Marc Hamoir; Alessandra Rinaldo; Alfio Ferlito
Journal:  Curr Oncol Rep       Date:  2020-11-14       Impact factor: 5.075

Review 3.  Prophylactic Central Neck Dissection for Papillary Thyroid Carcinoma with Clinically Uninvolved Central Neck Lymph Nodes: A Systematic Review and Meta-analysis.

Authors:  Lawrence Chen; Yi-Hsiu Wu; Chia-Hwa Lee; Hsin-An Chen; El-Wui Loh; Ka-Wai Tam
Journal:  World J Surg       Date:  2018-09       Impact factor: 3.352

4.  Risk factors for high-volume lymph node metastases in cN0 papillary thyroid microcarcinoma.

Authors:  Chunhao Liu; Yuewu Liu; Lei Zhang; Yunwei Dong; Shenbao Hu; Yu Xia; Bo Zhang; Yue Cao; Ziwen Liu; Ge Chen; Zhonghua Shang; Jinbao Yang; Qinghe Sun; Xiaoyi Li
Journal:  Gland Surg       Date:  2019-10

5.  Positive central lymph-nodes are underdiagnosed in patients with Bethesda V cytology in an endemic goiter region.

Authors:  Lindsay Hargitai; Stephanie Strobl; Oskar Koperek; Susanne Urach; Wolfgang Raber; Anton Staudenherz; Christian Scheuba; Philipp Riss
Journal:  Gland Surg       Date:  2020-04

6.  Impact of prophylactic unilateral central neck dissection needed for patients with papillary thyroid microcarcinoma.

Authors:  Young Jae Ryu; Jung Han Yoon
Journal:  Gland Surg       Date:  2020-04

7.  Association of the Preoperative Inflammation-Based Scores with TNM Stage and Recurrence in Patients with Papillary Thyroid Carcinoma: A Retrospective, Multicenter Analysis.

Authors:  Wenjie Chen; Tao Wei; Zhihui Li; Rixiang Gong; Jianyong Lei; Jingqiang Zhu; Tao Huang
Journal:  Cancer Manag Res       Date:  2020-03-11       Impact factor: 3.989

8.  Distinguishing Benign and Malignant Thyroid Nodules and Identifying Lymph Node Metastasis in Papillary Thyroid Cancer by Plasma N-Glycomics.

Authors:  Zejian Zhang; Karli R Reiding; Jianqiang Wu; Zepeng Li; Xiequn Xu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-25       Impact factor: 5.555

Review 9.  Prophylactic Central Neck Dissection in Well-differentiated Thyroid Cancer.

Authors:  Krešimir Gršić; Boris Bumber; Renata Curić Radivojević; Dinko Leović
Journal:  Acta Clin Croat       Date:  2020-06       Impact factor: 0.780

10.  Surgical Extent of Central Lymph Node Dissection for Papillary Thyroid Carcinoma Located in the Isthmus: A Propensity Scoring Matched Study.

Authors:  Yanjie Shuai; Kai Yue; Yuansheng Duan; Mengqian Zhou; Yan Fang; Jin Liu; Dandan Liu; Chao Jing; Yansheng Wu; Xudong Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-15       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.